- Home
- ARCT vs NBB Comparison
ARCT vs NBB Comparison
Compare ARCT & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | NBB |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.9M | 418.0M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ARCT | NBB |
|---|---|---|
| Price | $10.74 | $14.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | ★ 653.3K | 114.7K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.21 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $13.76 |
| 52 Week High | $17.96 | $16.62 |
Technical Indicators
Market Signals| Indicator | ARCT | NBB |
|---|---|---|
| Relative Strength Index (RSI) | 38.81 | 49.58 |
| Support Level | $6.53 | $13.97 |
| Resistance Level | $17.85 | $14.53 |
| Average True Range (ATR) | 1.13 | 0.18 |
| MACD | -0.26 | 0.06 |
| Stochastic Oscillator | 8.84 | 76.61 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund has single operating segment.